Which stocks are moving after the closing bell on Friday? The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data Cognition Therapeutics Inc (
NASDAQ: CGTX ) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge during regular market hours.
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns Sonnet BioTherapeutics Holdings Inc. (
NASDAQ: SONN ) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting.
Top movers in Thursday's after hours session Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
These stocks are moving in today's pre-market session Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference
Cognition Therapeutics Is Targeting A Critical Form Of Dementia Cognition Therapeutics Is Targeting A Critical Form Of Dementia
Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial
Why Is Penny Stock Cognition Therapeutics Trading Over 93% On Wednesday? Cognition Therapeutics' CT1812 improves dementia with Lewy bodies outcomes, reducing anxiety, hallucinations, and functional decline in trials.
November’s Small-Cap Treasures: 3 Stocks Poised for Growth Three promising small-cap stocks, poised for growth in healthcare, cybersecurity, and renewable energy, offer compelling investment opportunities for November.
CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q2 2024 CGTX stock results show that Cognition Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
Tivic Health Systems (TIVC) Stock Pops Another 39% Tivic Health Systems stock is up on Monday with heavy trading of TIVC shares as recent volatility continues for the company's units.
